Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 30.49-6.23-32.1036.7145.25

What is the latest Core EBITDA Growth ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Growth ratio of DIVIS LABORATORIES is 30.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202530.49
Mar2024-6.23
Mar2023-32.10
Mar202236.71
Mar202145.25

How is Core EBITDA Growth of DIVIS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 30.49
Positive
Mar2024 -6.23
Negative
Mar2023 -32.1
Negative
Mar2022 36.71
-18.87
Mar2021 45.25 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹182,831.3 Cr 4.4% 15.9% 15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,468.0 Cr -1.4% 3.6% -7.8% Stock Analytics
CIPLA ₹121,170.0 Cr -4.9% -0.8% 6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,300.0 Cr -0.6% 1.8% 15.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,575.0 Cr -4.1% -3.8% -4.3% Stock Analytics
MANKIND PHARMA ₹95,320.4 Cr -3.1% -3.3% -8.6% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

4.4%

15.9%

15.6%

SENSEX

-2%

2.6%

4.2%


You may also like the below Video Courses